No price history available.
Key financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CNYm | 564 | 628 | 742 | 658 | 605 | 463 | N/A | N/A |
| Operating profit | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | CNYm | 45 | 14 | 61 | 15 | 19 | -28 | N/A | N/A |
| EPS reported | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Hebei Jianxin Chemical Co., Ltd. researches and develops, manufactures, and sells dyes intermediates in China. The company offers metanilic acid, aniline-2, 5-disulfonic acid monosodium salt, 3- diethylaminophenol, m-aminophenol, sulfanilic acid, ODB-1, ODB-2, R-04, EBA, BBA, MMD, DPA, DBSP, BON, and n-butyl bromide. It also provides 3,3'-dinitrodiphenyl sulfone; 3,3'-diamino diphenyl sulphone; 4,4'-dichloro diphenyl sulphone; 4,4'-diamino diphenyl sulfone; and m-trihydroxybenzene. Its products are used as intermediates for dyes, medicine, fiber, pesticide, dyestuffs, and synthesizing health care products; OBA for paper; color formers for thermal and carbonless paper; and developer and sensitizer for thermal paper. The company’s products are also used as alkylating agent, solvent, and extracting agent for rare elements and organic synthesis; materials for curing agents, epoxy resins, engineering plastics, dyestuffs, polysulfone amides, and other polymers; monomer for polysulfonamide fiber; and pharmaceutical and auxiliary intermediates. It also exports its products to Europe, the United States, Japan, Korea, Taiwan, and Hong Kong. The company was incorporatedd in 2003 and is headquartered in Cangzhou, China.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Hebei Jianxin Chemical Co., Ltd. (300107.SZ)
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Hebei Jianxin Chemical Co., Ltd. researches and develops, manufactures, and sells dyes intermediates in China. The company offers metanilic acid, aniline-2, 5-disulfonic acid monosodium salt, 3- diethylaminophenol, m-aminophenol, sulfanilic acid, ODB-1, ODB-2, R-04, EBA, BBA, MMD, DPA, DBSP, BON, and n-butyl bromide. It also provides 3,3'-dinitrodiphenyl sulfone; 3,3'-diamino diphenyl sulphone; 4,4'-dichloro diphenyl sulphone; 4,4'-diamino diphenyl sulfone; and m-trihydroxybenzene. Its products are used as intermediates for dyes, medicine, fiber, pesticide, dyestuffs, and synthesizing health care products; OBA for paper; color formers for thermal and carbonless paper; and developer and sensitizer for thermal paper. The company’s products are also used as alkylating agent, solvent, and extracting agent for rare elements and organic synthesis; materials for curing agents, epoxy resins, engineering plastics, dyestuffs, polysulfone amides, and other polymers; monomer for polysulfonamide fiber; and pharmaceutical and auxiliary intermediates. It also exports its products to Europe, the United States, Japan, Korea, Taiwan, and Hong Kong. The company was incorporatedd in 2003 and is headquartered in Cangzhou, China.